Mark Hemmila

Dr. Mark Hemmila

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Annals of Surgery
Verified
Journal Article
Closed access
MHMark Hemmila
Mark Hemmila
SRStephen A. Rowe
Stephen A. Rowe
TBTamer N. Boules
Tamer N. Boules
JMJudiann Miskulin
Judiann Miskulin
JMJohn W. McGillicuddy
John W. McGillicuddy
RBRobert H. Bartlett
Robert H. Bartlett
Severe acute respiratory distress syndrome (ARDS) is associated with a high level of mortality. Extracorporeal life support (ECLS) during severe ARDS maintains oxygen and carbon dioxide gas exchange while providing an optimal environment for recovery of pulmonary function. Since 1989, we have used a protocol-driven algorithm for treatment of severe ARDS, which includes the use of ECLS when standard therapy fails. The objective of this study was to evaluate our experience with ECLS in adult patients with severe ARDS with respect to mortality and morbidity. We reviewed our complete experience with ELCS in adults from January 1, 1989, through December 31, 2003. Severe ARDS was defined as acute onset pulmonary failure, with bilateral infiltrates on chest x-ray, and PaO2/fraction of inspired oxygen (FiO2) ratio < or =100 or A-aDO2 >600 mm Hg despite maximal ventilator settings. The indication for ECLS was acute severe ARDS unresponsive to optimal conventional treatment. The technique of ECLS included veno-venous or veno-arterial vascular access, lung "rest" at low FiO2 and inspiratory pressure, minimal anticoagulation, and optimization of systemic oxygen delivery. During the study period, ECLS was used for 405 adult patients age 17 or older. Of these 405 patients, 255 were placed on ECLS for severe ARDS refractory to all other treatment. Sixty-seven percent were weaned off ECLS, and 52% survived to hospital discharge. Multivariate logistic regression analysis identified the following pre-ELCS variables as significant independent predictors of survival: (1) age (P = 0.01); (2) gender (P = 0.048); (3) pH < or =7.10 (P = 0.01); (4) PaO2/FiO2 ratio (P = 0.03); and (5) days of mechanical ventilation (P < 0.001). None of the patients who survived required permanent mechanical ventilation or supplemental oxygen therapy. Extracorporeal life support for severe ARDS in adults is a successful therapeutic option in those patients who do not respond to conventional mechanical ventilator strategies.

1 February 2010 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
MHMark Hemmila
Mark Hemmila
ANAvery B. Nathens
Avery B. Nathens
SSShahid Shafi
Shahid Shafi
JCJ. Forrest Calland
J. Forrest Calland
DCDavid E. Clark
David E. Clark
JFJohn J. Fildes
John J. Fildes
The American College of Surgeons Committee on Trauma has created a “Trauma Quality Improvement Program” (TQIP) that uses the existing infrastructure of Committee on Trauma programs. As the first step toward full implementation of TQIP, a pilot study was conducted in 23 American College of Surgeons verified or state designated Level I and II trauma centers. This study details the feasibility and acceptance of TQIP among the participating centers. Data from the National Trauma Data Bank for patients admitted to pilot study hospitals during 2007 were used (15,801 patients). A multivariable logistic regression model was developed to estimate risk-adjusted mortality in aggregate and on three prespecified subgroups (1: blunt multisystem, 2: penetrating truncal, and 3: blunt single-system injury). Benchmark reports were developed with each center's risk adjusted mortality (expressed as an observed-to-expected [O/E] mortality ratio and 90% confidence interval [CI]) and crude complication rates available for comparison. Reports were deidentified with only the recipient having access to their performance relative to their peers. Feedback from individual centers regarding the utility of the reports was collected by survey. Overall crude mortality was 7.7% and in cohorts 1 to 3 was 16.4%, 12.4%, and 5.1%, respectively. In the aggregate risk-adjusted analysis, three trauma centers were low outliers (O/E and 90% CI 1) with the remaining 18 centers demonstrating average mortality. Challenges identified were in benchmarking mortality after penetrating injury due to small sample size and in the limited capture of complications. Ninety-two percent of survey respondents found the report clear and understandable, and 90% thought that the report was useful. Sixty-three percent of respondents will be taking action based on the report. Using the National Trauma Data Bank infrastructure to provide risk-adjusted benchmarking of trauma center mortality is feasible and perceived as useful. There are differences in O/E ratios across similarly verified or designated centers. Substantial work is required to allow for morbidity benchmarking.

1 October 2008 in Surgery
Verified
Journal Article
Closed access
MHMark Hemmila
Mark Hemmila
MTMichael A. Taddonio
Michael A. Taddonio
SASaman Arbabi
Saman Arbabi
PMPaul M. Maggio
Paul M. Maggio
WWWendy L. Wahl
Wendy L. Wahl

1 October 2010 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
MHMark Hemmila
Mark Hemmila
NBNancy J. Birkmeyer
Nancy J. Birkmeyer
SASaman Arbabi
Saman Arbabi
NONicholas H. Osborne
Nicholas H. Osborne
WWWendy L. Wahl
Wendy L. Wahl
JDJustin B. Dimick
Justin B. Dimick
Research from JAMA Surgery — Introduction to Propensity Scores — A Case Study on the Comparative Effectiveness of Laparoscopic vs Open Appendectomy

1 July 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
BJBenjamin N. Jacobs
Benjamin N. Jacobs
ACAnne H. Cain-Nielsen
Anne H. Cain-Nielsen
JJJill L. Mhsa Jakubus
Jill L. Mhsa Jakubus
JMJudy N. Mikhail
Judy N. Mikhail
JFJohn J. Fath
John J. Fath
MHMark Hemmila
Mark Hemmila
BACKGROUND Venous thromboembolism (VTE) is a common complication in trauma patients. Pharmacologic prophylaxis is utilized in trauma patients to reduce their risk of a VTE event. The Eastern Association for the Surgery of Trauma guidelines recommend use of low-molecular-weight heparin (LMWH) as the preferred agent in these patients. However, there is literature suggesting that unfractionated heparin (UFH) is an acceptable, and less costly, alternative VTE prophylaxis agent with equivalent efficacy in trauma patients. We examined data from the Michigan Trauma Quality Improvement Program to perform a comparative effectiveness study of UFH versus LMWH on outcomes for trauma patients. METHODS We conducted an analysis of the Michigan Trauma Quality Improvement Program data from January 2012 to December 2014. The data set contains information on date, time, and drug type of the first dose of VTE prophylaxis. Thirty-seven thousand eight hundred sixty-eight patients from 23 hospitals were present with an Injury Severity Score of 5 or greater and hospitalization for more than 24 hours. Patients were excluded if they died within 24 hours or received no pharmacologic VTE prophylaxis or agents other than UFH or LMWH while admitted to the hospital. We compared patients receiving LMWH to those receiving UFH. Outcomes assessed were VTE event, pulmonary embolism, deep vein thrombosis, and mortality during hospitalization. We used a generalized estimating equation approach to fit population-averaged logistic regression models with the type of first dose of VTE prophylaxis as the independent variable. Unfractionated heparin was considered the reference value. Timing of the first dose of VTE prophylaxis was entered into the model in addition to standard covariates. Odds ratios were generated for each of the dependent variables of interest. RESULTS The analysis cohort consisted of 18,010 patients. Patients administered LMWH had a decreased risk of mortality (odds ratio, 0.64; confidence interval, 0.49–0.83), VTE (odds ratio, 0.67; confidence interval, 0.53–0.84), pulmonary embolism (odds ratio, 0.53; confidence interval, 0.35–0.79), and deep vein thrombosis (odds ratio, 0.73; confidence interval, 0.57–0.95) when compared with UFH following risk adjustment and accounting for hospital effect. The reduced risk of a VTE event for patients receiving LMWH was most pronounced for patients in the lower injury-severity categories. CONCLUSIONS In our examination of VTE prophylaxis drug effectiveness, LMWH was found to be superior to UFH in reducing the incidence of mortality and VTE events among trauma patients. Therefore, LMWH should be the preferred VTE prophylaxis agent for use in hospitalized trauma patients. LEVEL OF EVIDENCE Therapeutic, level III.

1 August 2008 in Surgery
Verified
Journal Article
Closed access
MHMark Hemmila
Mark Hemmila
JJJill L. Jakubus
Jill L. Jakubus
PMPaul M. Maggio
Paul M. Maggio
WWWendy L. Wahl
Wendy L. Wahl
JDJustin B. Dimick
Justin B. Dimick
PTPaul A. Taheri
Paul A. Taheri